Cipla has a significant presence in urology, with products in prostate ailments – BPH (Benign Prostatic Hyperplasia), prostate cancer, bladder disorders, urinary stones, hypogonadism and sexual dysfunction ailments. Besides developing many of India’s firsts in this therapy, we have to our credit the world’s first combination products containing Tamsulosin + Finasteride and Tamsulosin + Dutasteride…milestones in the history of urology.

Some of our other important products in urology include:

  • A selective alpha-blocker that reduces the chances of surgery for BPH patients.
  • Bicalutamide – for prostate cancer.
  • Potassium citrate and Magnesium citrate solution – for the treatment and management of urinary stones.

To maintain our leadership position, we work closely with urologists and surgeons and support a range of initiatives for those working in the field of urology. We export our urology products to several countries around the globe.